Latest News

Broker Forecast - Canaccord Genuity issues a broker note on Silence Therapeutics PLC

Canaccord Genuity today reaffirms its buy investment rating on Silence Therapeutics PLC (LON:SLN) and raised its price...

Silence Therapeutics widens H1 loss

Silence Therapeutics has turned in an H1 pretax loss of 5.5m, from a year-earlier's loss of 4.1m. "Silence has been fully focus...

Half-year Report

RNS Number: 8769K Silence Therapeutics PLC 27 September 2016 27 Sept e mber 2 0 16 I n t e r i m results for the six months ended 30 June 2016 Liver focus, patent portfolio validation and strengthened leadership L o n d o n , 27 S e p t emb e r 2 0 1 6 - Sil e n ce Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery and developm...

Notice of Results

RNS Number: 4927K Silence Therapeutics PLC 22 September 2016 22 September 2016 Notice of Results London, 22 September 2016 - Silence Therapeutics plc, AIM:SLN ("Silence" or the "the Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, will announce results f...

All News

27-09-16Broker Forecast - Canaccord Genuity issues a broker note on Silence Therapeutics PLCStockMarketWire
27-09-16Silence Therapeutics widens H1 lossStockMarketWire
27-09-16Half-year ReportRNS
22-09-16Notice of ResultsRNS
05-09-16Appointment of CSO and Non-Executive DirectorRNS
18-07-16Director/PDMR ShareholdingRNS
17-06-16Silence resolutions passed at AGMStockMarketWire
17-06-16Result of AGMRNS
01-06-16Holding(s) in CompanyRNS
24-05-16Board Changes, Advisory Board and Notice of AGMRNS
03-05-16Silence Therapeutics Plc to present at the SHARES Investor Evening in London on 19th MayStockMarketWire
19-04-16Director/PDMR ShareholdingRNS
18-04-16Director/PDMR ShareholdingRNS
18-04-16Grant of share options to Chief ExecutiveRNS
05-04-16Should You Dump AstraZeneca plc And Buy BTG plc & Silence Therapeutics plc?Motley Fool
05-04-16SLN updates on Atu027-I-02 studyStockMarketWire
05-04-16Silence Therapeutics narrows FY pretax lossStockMarketWire
05-04-16Final ResultsRNS
05-04-16Atu027 UpdateRNS
30-03-16Holding(s) in CompanyRNS
22-03-16Notice of ResultsRNS
18-01-16Board changesRNS
12-11-15Board appointmentRNS
30-10-15Licensee's drug to commence Ph 2/Ph 3 trialsRNS
29-09-15Interim ResultsRNS
22-09-15Board Change and Notice of ResultsRNS
28-08-15AIM share consolidations: winners and losersInteractive Investor
30-07-15Interim Board ChangeRNS
12-06-15Meet AIM's survivors 20 years onInteractive Investor
01-06-15Result of AGMRNS
01-06-15SLN updates on pancreatic cancer trial interim analysisStockMarketWire
01-06-15AGM statement and clinical trial interim analysisRNS
14-05-15Replacement: Holding(s) in CompanyRNS
14-05-15Silence Therapeutics gives clinical trial update StockMarketWire
14-05-15Clinical trial updateRNS
12-05-15Holding(s) in CompanyRNS
11-05-15Holding(s) in CompanyRNS
11-05-15Holding(s) in CompanyRNS
11-05-15Holding(s) in CompanyRNS
11-05-15Silence Therapeutics schedules AGMStockMarketWire

RSS feeds

  • Editorial news feed for LSE:SLN Editorial
  • Regulatory news feed for LSE:SLN Regulatory